Biotech

All Articles

Bicara, Zenas find IPOs to push late-phase properties toward market

.Bicara Therapeutics and also Zenas Biopharma have actually provided fresh catalyst to the IPO marke...

Genentech to close cancer cells immunology investigation team

.Genentech will definitely close its cancer immunology study division, as well as device mind and al...

Kezar goes down sound growth however to show its own truly worth in phase 1 test

.Kezar Lifestyle Sciences is falling its dim stage 1 solid tumor drug as the biotech goes all-in on ...

Acelyrin drops izokibep, lets go 3rd of personnel

.Regardless of izokibep keeping its own newfound winning touch in the center, Acelyrin is no longer ...

Rivus' phase 2 obesity-related cardiac arrest test hits endpoint

.Rivus Pharmaceuticals has actually plumped up the customers of its own fat-busting, muscle-sparing ...

Ovid standstills preclinical work, IV program after soticlestat fail

.Ovid Therapy already disclosed last month that it was trimming back its head count as the business ...

Eli Lilly opens up $700M nucleic acid R&ampD facility in Boston ma Seaport

.Eli Lilly has actually opened a $700 million R&ampD center in the Boston ma Seaport, boosting its o...

Boundless Biography helps make 'reasonable' discharges five months after $100M IPO

.Just five months after securing a $100 thousand IPO, Boundless Biography is actually laying off som...

Halda's $126M will definitely advance 'keep as well as eliminate' cyst medications

.The first stages of oncology R&ampD may not be short of interesting new methods, and Halda Therapie...

Lykos 'disappointments' certainly not disclosing study violations along with publisher

.Psychopharmacology has taken three posts concerning midstage medical test data assessing Lykos Reha...